S&P 500   4,288.39 (+0.01%)
DOW   33,433.35 (-0.22%)
QQQ   361.26 (+0.83%)
AAPL   173.75 (+1.48%)
MSFT   321.80 (+1.92%)
META   306.82 (+2.20%)
GOOGL   134.17 (+2.53%)
AMZN   129.46 (+1.84%)
TSLA   251.60 (+0.55%)
NVDA   447.82 (+2.95%)
NIO   8.79 (-2.77%)
BABA   86.53 (-0.24%)
AMD   103.27 (+0.44%)
T   14.67 (-2.33%)
F   12.31 (-0.89%)
MU   67.96 (-0.10%)
CGC   0.74 (-5.85%)
GE   108.79 (-1.59%)
DIS   81.67 (+0.76%)
AMC   8.15 (+2.00%)
PFE   33.94 (+2.32%)
PYPL   58.56 (+0.17%)
NFLX   380.33 (+0.72%)
S&P 500   4,288.39 (+0.01%)
DOW   33,433.35 (-0.22%)
QQQ   361.26 (+0.83%)
AAPL   173.75 (+1.48%)
MSFT   321.80 (+1.92%)
META   306.82 (+2.20%)
GOOGL   134.17 (+2.53%)
AMZN   129.46 (+1.84%)
TSLA   251.60 (+0.55%)
NVDA   447.82 (+2.95%)
NIO   8.79 (-2.77%)
BABA   86.53 (-0.24%)
AMD   103.27 (+0.44%)
T   14.67 (-2.33%)
F   12.31 (-0.89%)
MU   67.96 (-0.10%)
CGC   0.74 (-5.85%)
GE   108.79 (-1.59%)
DIS   81.67 (+0.76%)
AMC   8.15 (+2.00%)
PFE   33.94 (+2.32%)
PYPL   58.56 (+0.17%)
NFLX   380.33 (+0.72%)
S&P 500   4,288.39 (+0.01%)
DOW   33,433.35 (-0.22%)
QQQ   361.26 (+0.83%)
AAPL   173.75 (+1.48%)
MSFT   321.80 (+1.92%)
META   306.82 (+2.20%)
GOOGL   134.17 (+2.53%)
AMZN   129.46 (+1.84%)
TSLA   251.60 (+0.55%)
NVDA   447.82 (+2.95%)
NIO   8.79 (-2.77%)
BABA   86.53 (-0.24%)
AMD   103.27 (+0.44%)
T   14.67 (-2.33%)
F   12.31 (-0.89%)
MU   67.96 (-0.10%)
CGC   0.74 (-5.85%)
GE   108.79 (-1.59%)
DIS   81.67 (+0.76%)
AMC   8.15 (+2.00%)
PFE   33.94 (+2.32%)
PYPL   58.56 (+0.17%)
NFLX   380.33 (+0.72%)
S&P 500   4,288.39 (+0.01%)
DOW   33,433.35 (-0.22%)
QQQ   361.26 (+0.83%)
AAPL   173.75 (+1.48%)
MSFT   321.80 (+1.92%)
META   306.82 (+2.20%)
GOOGL   134.17 (+2.53%)
AMZN   129.46 (+1.84%)
TSLA   251.60 (+0.55%)
NVDA   447.82 (+2.95%)
NIO   8.79 (-2.77%)
BABA   86.53 (-0.24%)
AMD   103.27 (+0.44%)
T   14.67 (-2.33%)
F   12.31 (-0.89%)
MU   67.96 (-0.10%)
CGC   0.74 (-5.85%)
GE   108.79 (-1.59%)
DIS   81.67 (+0.76%)
AMC   8.15 (+2.00%)
PFE   33.94 (+2.32%)
PYPL   58.56 (+0.17%)
NFLX   380.33 (+0.72%)

Ingevity (NGVT) Stock Forecast, Price & News

$46.40
-1.21 (-2.54%)
(As of 05:20 PM ET)
Compare
Today's Range
$46.01
$47.73
50-Day Range
$46.86
$64.31
52-Week Range
$46.01
$90.81
Volume
197,932 shs
Average Volume
319,088 shs
Market Capitalization
$1.68 billion
P/E Ratio
9.85
Dividend Yield
N/A
Price Target
$63.33

Ingevity MarketRank™ Forecast

Analyst Rating
Hold
2.33 Rating Score
Upside/​Downside
36.4% Upside
$63.33 Price Target
Short Interest
Healthy
2.78% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
32.84%
From $4.08 to $5.42 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.83 out of 5 stars

Basic Materials Sector

26th out of 168 stocks

Chemicals & Allied Products Industry

6th out of 14 stocks


NGVT stock logo

About Ingevity (NYSE:NGVT) Stock

Ingevity Corporation manufactures and sells specialty chemicals and activated carbon materials in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through two segments, Performance Materials and Performance Chemicals. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products primarily for use in gasoline vapor emission control systems in cars, motorcycles, trucks, and boats. This segment also produces other activated carbon products for use in various applications, including food, water, beverage, and chemical purification. The Performance Chemicals segment comprises of pavement technologies, industrial specialties, and engineered polymers. It manufactures products derived from crude tall oil and lignin extracted from the kraft pulping process, as well as caprolactone monomers and derivatives derived from cyclohexanone and hydrogen peroxide. This segment's products are used in various applications comprising warm mix paving, pavement preservation, pavement reconstruction and recycling, road striping, oil well service additives, oil production, and downstream applications; and adhesives, agrochemical dispersants, lubricants, printing inks, industrial intermediates and oilfield, coatings, resins, elastomers, bioplastics, and medical devices. The company was founded in 1964 and is headquartered in North Charleston, South Carolina.

NGVT Price History

NGVT Stock News Headlines

Elon Did It Again: This Could be Bigger than Tesla
Love him or hate him, it’s hard to deny Elon Musk is a genius. After revolutionizing online payment processing (PayPal), space exploration (SpaceX), and the auto industry (Tesla)... He’s getting ready to do it again with his new AI venture.
Are "The Magnificent Seven" the Next Sears?
The former retail giant’s sales once accounted for 1% of the U.S. economy. Now it’s nearly extinct. Will the same happen to big tech? Learn more here.
BMO Capital downgrades Ingevity (NGVT) to a Hold
Ingevity reports second quarter 2023 financial results
Ingevity (NGVT) Meets Q2 Earnings Estimates
What Wall Street expects from Ingevity's earnings
Analyst Expectations for Ingevity's Future
Loop Capital Upgrades Ingevity (NGVT)
What 7 Analyst Ratings Have To Say About Ingevity
See More Headlines
Receive NGVT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ingevity and its competitors with MarketBeat's FREE daily newsletter.

NGVT Company Calendar

Last Earnings
8/02/2023
Today
10/02/2023
Next Earnings (Estimated)
11/01/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Chemicals & allied products
Sub-Industry
N/A
Previous Symbol
NASDAQ:NGVT
Employees
2,050
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$63.33
High Stock Price Forecast
$75.00
Low Stock Price Forecast
$55.00
Forecasted Upside/Downside
+36.5%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
3 Analysts

Profitability

Net Income
$211.60 million
Pretax Margin
13.06%

Debt

Sales & Book Value

Annual Sales
$1.67 billion
Cash Flow
$8.87 per share
Book Value
$18.68 per share

Miscellaneous

Free Float
35,938,000
Market Cap
$1.68 billion
Optionable
Optionable
Beta
1.87
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. John C. Fortson (Age 56)
    Pres, CEO & Director
    Comp: $2.57M
  • Ms. Mary Dean Hall (Age 65)
    Exec. VP & CFO
    Comp: $1.14M
  • Ms. Stacy Lancaster Cozad (Age 52)
    Exec. VP, Gen. Counsel & Sec.
    Comp: $1.05M
  • Mr. Stuart Edward Woodcock Jr.Mr. Stuart Edward Woodcock Jr. (Age 57)
    Exec. VP & Pres of Performance Materials
    Comp: $960.98k
  • Mr. Richard White (Age 60)
    Sr. VP & Pres of Performance Chemicals
    Comp: $854.88k
  • Mr. Phillip John Platt (Age 42)
    VP, Chief Accounting Officer & Bus. Transformation Lead
  • John E. Nypaver Jr.
    VP of Investor Relations & Treasurer
  • Caroline Monahan
    Director of Communications
  • Ms. Christine Stunyo (Age 44)
    Sr. VP & Chief HR Officer
  • Mr. Steve Hulme (Age 54)
    Sr. VP & Pres of Advanced Polymer Technologies













NGVT Stock - Frequently Asked Questions

Should I buy or sell Ingevity stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Ingevity in the last year. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" NGVT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NGVT, but not buy additional shares or sell existing shares.
View NGVT analyst ratings
or view top-rated stocks.

What is Ingevity's stock price forecast for 2023?

3 analysts have issued twelve-month price targets for Ingevity's stock. Their NGVT share price forecasts range from $55.00 to $75.00. On average, they expect the company's stock price to reach $63.33 in the next year. This suggests a possible upside of 36.5% from the stock's current price.
View analysts price targets for NGVT
or view top-rated stocks among Wall Street analysts.

How have NGVT shares performed in 2023?

Ingevity's stock was trading at $70.44 on January 1st, 2023. Since then, NGVT shares have decreased by 34.1% and is now trading at $46.40.
View the best growth stocks for 2023 here
.

When is Ingevity's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 1st 2023.
View our NGVT earnings forecast
.

How were Ingevity's earnings last quarter?

Ingevity Co. (NYSE:NGVT) announced its quarterly earnings data on Wednesday, August, 2nd. The company reported $1.41 earnings per share for the quarter, hitting analysts' consensus estimates of $1.41. The firm earned $481.80 million during the quarter, compared to the consensus estimate of $486.43 million. Ingevity had a trailing twelve-month return on equity of 27.94% and a net margin of 10.18%. The company's quarterly revenue was up 14.7% compared to the same quarter last year. During the same period in the previous year, the company earned $1.73 EPS.

What ETFs hold Ingevity's stock?
What guidance has Ingevity issued on next quarter's earnings?

Ingevity updated its FY 2023 earnings guidance on Wednesday, August, 2nd. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $1.60 billion-$1.70 billion, compared to the consensus revenue estimate of $1.82 billion.

What is John Fortson's approval rating as Ingevity's CEO?

2 employees have rated Ingevity Chief Executive Officer John Fortson on Glassdoor.com. John Fortson has an approval rating of 100% among the company's employees. This puts John Fortson in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Ingevity own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Ingevity investors own include Pfizer (PFE), AbbVie (ABBV), General Electric (GE), Verizon Communications (VZ), WestRock (WRK), Abbott Laboratories (ABT), Boeing (BA), Costco Wholesale (COST), Dominion Energy (D) and Johnson & Johnson (JNJ).

What is Ingevity's stock symbol?

Ingevity trades on the New York Stock Exchange (NYSE) under the ticker symbol "NGVT."

How do I buy shares of Ingevity?

Shares of NGVT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Ingevity's stock price today?

One share of NGVT stock can currently be purchased for approximately $46.40.

How much money does Ingevity make?

Ingevity (NYSE:NGVT) has a market capitalization of $1.68 billion and generates $1.67 billion in revenue each year. The company earns $211.60 million in net income (profit) each year or $4.71 on an earnings per share basis.

How many employees does Ingevity have?

The company employs 2,050 workers across the globe.

How can I contact Ingevity?

Ingevity's mailing address is 4920 O`Hear Avenue Suite 400, North Charleston SC, 29406. The official website for the company is www.ingevity.com. The company can be reached via phone at (843) 740-2300, via email at daniel.gallagher@ingevity.com, or via fax at 843-740-8165.

This page (NYSE:NGVT) was last updated on 10/2/2023 by MarketBeat.com Staff

My Account -